These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2134619)

  • 1. Platelet phospholipid antigen-antibody interactions: detection and biological relevance.
    Rauch J
    Transfus Med Rev; 1990 Apr; 4(2):110-4. PubMed ID: 2134619
    [No Abstract]   [Full Text] [Related]  

  • 2. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease.
    Drouvalakis KA; Buchanan RR
    J Rheumatol; 1998 Feb; 25(2):290-5. PubMed ID: 9489821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus anticoagulant antibodies: recognition of phospholipid-binding protein complexes.
    Rauch J
    Lupus; 1998; 7 Suppl 2():S29-31. PubMed ID: 9814668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune thrombophilic syndromes.
    Greaves M
    Haematologica; 1999 Jun; 84 Suppl EHA-4():32-5. PubMed ID: 10907462
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal antibody immunospecific platelet assay in patients with lupus anticoagulant and prolonged bleeding time: Comment on the article by Urbanus et al.
    Schleinitz N; Camoin L; Bernit E; Reviron D; Veit V; Harlé JR
    Arthritis Rheum; 2005 Jun; 52(6):1949; author reply 1949-50. PubMed ID: 15934060
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between the lupus anticoagulant, anticardiolipin antibodies and antiphospholipid antibodies.
    Tomer Y; Shoenfeld Y
    Isr J Med Sci; 1992 Jan; 28(1):38-40. PubMed ID: 1733897
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a phospholipid specificity of lupus anticoagulants (LAC) in patients with autoimmune and drug induced LAC?
    Hess EV
    J Rheumatol; 1998 Feb; 25(2):200-2. PubMed ID: 9489806
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiphospholipid syndrome].
    Wisłowska M
    Wiad Lek; 1992 Jun; 45(11-12):450-3. PubMed ID: 1441529
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiphospholipid antibodies--lobsters or red herrings?
    Rote NS; Walter A; Lyden TW
    Am J Reprod Immunol; 1992 Aug; 28(1):31-7. PubMed ID: 1418414
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiphospholipid antibodies in systemic lupus erythematosus.
    Ichikawa Y; Shimizu H; Moriuchi J; Uchiyama M; Takaya M; Arimori S; Kobayashi N; Watanabe K; Kawada T; Tanaka Y
    Tokai J Exp Clin Med; 1990 May; 15(2-3):241-4. PubMed ID: 2130530
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.
    Sthoeger ZM; Tartakovsky B; Bentwich Z; Mozes E
    J Clin Immunol; 1993 Mar; 13(2):127-38. PubMed ID: 7686561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What causes the antiphospholipid syndrome?
    Merrill JT
    Curr Rheumatol Rep; 2001 Aug; 3(4):293-300. PubMed ID: 11470047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiphospholipid-protein antibodies. Effects on the endothelium-platelet interaction].
    Forastiero RR; Martinuzzo ME; Carreras LO
    Sangre (Barc); 1999 Jun; 44(3):223-30. PubMed ID: 10481585
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiphospholipid antibodies: a review.
    Harris EN; Gharavi AE; Asherson RA; Hughes GR
    Eur J Rheumatol Inflamm; 1984; 7(1):5-8. PubMed ID: 6443722
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet antibody binding and spontaneous aggregation in 21 lupus anticoagulant patients.
    Wiener HM; Vardinon N; Yust I
    Vox Sang; 1991; 61(2):111-21. PubMed ID: 1763496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Many faces of lupus anticoagulants.
    Triplett DA
    Lupus; 1998; 7 Suppl 2():S18-22. PubMed ID: 9814666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies: is there a role in cardiac valvular disease and its thromboembolic complications?
    Nardone Soscia P; Romain PL
    Cardiology; 1992; 80(1):1-6. PubMed ID: 1555211
    [No Abstract]   [Full Text] [Related]  

  • 20. Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients.
    Formiga F; Mitjavila F; Pac M; Moga I
    Lupus; 1997; 6(5):486. PubMed ID: 9229372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.